Abstract |
The paper is devoted to assessment of isometronidazole tolerance, used as a radiosensitizer for preoperative irradiation of lung cancer patients, and to characterization of morphological postradiation changes in tissues of carcinomas removed at operation. Isometronidazole was shown to cause no severe side-effects in patients, improving considerably radiation injury of the tumor parenchyma.
|
Authors | V V Zharkov, K Kh Merkle, M Gentshel, A V Furmanchuk, V P Kurchin, Iu E Demidchik, P I Moiseev |
Journal | Meditsinskaia radiologiia
(Med Radiol (Mosk))
Vol. 36
Issue 7
Pg. 18-20
( 1991)
ISSN: 0025-8334 [Print] Russia (Federation) |
Vernacular Title | Neposredstvennye rezul'taty primeneniia izometronidazola pri kombinirovannom lechenii bol'nykh rakom legkogo. |
PMID | 1881282
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
- Radiation-Sensitizing Agents
- Metronidazole
- isometronidazole
|
Topics |
- Adult
- Combined Modality Therapy
- Humans
- Lung Neoplasms
(drug therapy, radiotherapy, surgery)
- Male
- Metronidazole
(analogs & derivatives, therapeutic use)
- Middle Aged
- Radiation-Sensitizing Agents
(therapeutic use)
|